Quanterix Corporation
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
FIGI: BBG0027NWC69
QTRX
Quanterix Corporation
GICS: -
·
Sektor: Healthcare
·
Sub-Sektor: Medical Devices
NAME
Quanterix Corporation
ISIN
US74766Q1013
TICKER
QTRX
MIC
XNAS
REUTERS
QTRX.OQ
BLOOMBERG
QTRX US
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Mo., 06.01.2025
Quanterix
US74766Q1013
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that David R. Walt, co-inventor of the Company’s Simoa technology has received the National Medal of Technology and Innovation, bestowed by the President of the United States.
Since it was first awarded in 1985...
Quanterix
Do., 02.01.2025
Quanterix
US74766Q1013
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will present at the 43rd Annual J.P. Morgan Healthcare Conference taking place January 13th-16th at the Westin St. Francis Hotel in San Francisco, CA. Quan...
Quanterix
Di., 17.12.2024
Quanterix
US74766Q1013
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the acquisition of EMISSION iNC. (“EMISSION”). Quanterix expects the transaction will close in January 2025.
“As we expand our technology stack toward higher multi-plex and multi-om...
Quanterix
Fr., 22.11.2024
Quanterix
US74766Q1013
Quanterix Corporation (NASDAQ: QTRX) today announced that it received a notice (the “Notice”) on November 21, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Form 10-Q"), it is no longer in compliance with Nasdaq Lis...
Quanterix
Do., 21.11.2024
Quanterix
US74766Q1013
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Quanterix Corporation (NASDAQ: QTRX) resulting from allegations that Quanterix may have issued materially misleading business information to the investing public.
So What: If you purchased Quanterix secur...
Quanterix
Do., 14.11.2024
Quanterix
US74766Q1013
Law Offices of Howard G. Smith announces an investigation on behalf of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX) investors concerning the Company’s possible violations of federal securities laws.
On November 12, 2024, after market hours, Quanterix disclosed that it had “identified an error related to the capitalization ...
Quanterix
Do., 14.11.2024
Quanterix
US74766Q1013
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation (“Quanterix” or “the Company”) (NASDAQ: QTRX) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed...
Quanterix
Do., 14.11.2024
Quanterix
US74766Q1013
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on your Quan...
Quanterix
Mi., 13.11.2024
Quanterix
US74766Q1013
The Law Offices of Frank R. Cruz announces an investigation of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ:QTRX) on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On November 12, 2024, after market hours, Quan...
Quanterix
Di., 12.11.2024
Quanterix
US74766Q1013
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced preliminary financial results for the third quarter ended September 30, 2024 and reaffirmed its full year 2024 guidance. The Company also disclosed the need to restate certain prior period financial statements t...
Quanterix
Informationen zu Product Placements
SMART * AD
P R O D U C T S U G G E S T I O N S
